Sustained Long-Term Control of Terminal Complement Activity With Ravulizumab or Danicopan Add-On to Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

  • Patriquin, Christopher; 
  • de Latour, Regis Peffault; 
  • Sica, Simona; 
  • Brodsky, Robert; 
  • Nishimura, Ichi; 
  • ... Jang, Jun Ho; 
  • 외 3명
Citations

WEB OF SCIENCE

0

키워드

MDS; myelodysplastic syndromes; paroxysmal nocturnal hemoglobinuria (PNH); phase 3
제목
Sustained Long-Term Control of Terminal Complement Activity With Ravulizumab or Danicopan Add-On to Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria
저자
Patriquin, Christopher; de Latour, Regis Peffault; Sica, Simona; Brodsky, Robert; Nishimura, Ichi; Jang, Jun Ho; Patel, Yogesh; Yu, Ji; Schrezenmeier, Hubert
발행일
2026-08
유형
Meeting Abstract
저널명
Clinical Lymphoma, Myeloma and Leukemia
권
26
페이지
S723 ~ S723